Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Marín

Showing results (1-10 of 450) with videos related to

Pageof 45
Sort By:
Thrombosis and Haemostasis|April 7, 2018
Optimizing Vitamin K Antagonist Treatment in Patients with Mechanical Heart Valve ProsthesisVanessa Roldán, Francisco Marín
Thrombosis and Haemostasis|November 8, 2008
Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybodyVanessa Roldán, Francisco Marín
Thrombosis and Haemostasis|May 26, 2012
Oral anticoagulation in chronic kidney disease: A huge challengeVanessa Roldán, Francisco Marín
Nature Reviews. Cardiology|November 26, 2014
Biomarkers: GDF-15 and risk stratification in atrial fibrillationFrancisco Marín, Vanessa Roldán
Revista Espanola De Cardiologia (English Ed.)|May 11, 2016
On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013Inmaculada Roldán, Francisco Marín, , et al.
Thrombosis and Haemostasis|August 25, 2012
Pro: "Antidote for new anticoagulants"--specific target of inhibition requires a specific target for neutralisationVanessa Roldán, Francisco Marín
Revista Espanola De Cardiologia (English Ed.)|May 8, 2026
New opportunities and challenges in anticoagulationFrancisco Marín, Inmaculada Roldán,
International Journal of Cardiology|May 20, 2018
Oral anticoagulation and comorbidities; too many details for clinical practice?Francisco Marín, Vanessa Roldán
Thrombosis and Haemostasis|July 15, 2016
Assessment of bleeding risk in acute ill medical patients. An essential part of venous thromboembolism preventionVanessa Roldan, Francisco Marín
Thrombosis and Haemostasis|March 10, 2017
Predicting bleeding risk after coronary surgery: Let's focus on modifiable risk factors and simple, practical decision makingVanessa Roldán, Francisco Marín
Pageof 45

Showing results (1-10 of 450) with videos related to

Sort By:
Pageof 45
Thrombosis and Haemostasis|April 7, 2018
Optimizing Vitamin K Antagonist Treatment in Patients with Mechanical Heart Valve ProsthesisVanessa Roldán, Francisco Marín
Thrombosis and Haemostasis|November 8, 2008
Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybodyVanessa Roldán, Francisco Marín
Thrombosis and Haemostasis|May 26, 2012
Oral anticoagulation in chronic kidney disease: A huge challengeVanessa Roldán, Francisco Marín
Nature Reviews. Cardiology|November 26, 2014
Biomarkers: GDF-15 and risk stratification in atrial fibrillationFrancisco Marín, Vanessa Roldán
Revista Espanola De Cardiologia (English Ed.)|May 11, 2016
On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013Inmaculada Roldán, Francisco Marín, , et al.
Thrombosis and Haemostasis|August 25, 2012
Pro: "Antidote for new anticoagulants"--specific target of inhibition requires a specific target for neutralisationVanessa Roldán, Francisco Marín
Revista Espanola De Cardiologia (English Ed.)|May 8, 2026
New opportunities and challenges in anticoagulationFrancisco Marín, Inmaculada Roldán,
International Journal of Cardiology|May 20, 2018
Oral anticoagulation and comorbidities; too many details for clinical practice?Francisco Marín, Vanessa Roldán
Thrombosis and Haemostasis|July 15, 2016
Assessment of bleeding risk in acute ill medical patients. An essential part of venous thromboembolism preventionVanessa Roldan, Francisco Marín
Thrombosis and Haemostasis|March 10, 2017
Predicting bleeding risk after coronary surgery: Let's focus on modifiable risk factors and simple, practical decision makingVanessa Roldán, Francisco Marín
Pageof 45